Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

---
Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
Vote:
0 0
Previous CHENGDU POLY TIME EDITION: Redefining Urban Life in Asia-Pacific Through Sports and Community
Next Air Products to Expand Industrial Gas Supply for Samsung Electronics' Next-Generation Semiconductor Fab in South Korea

Related News

Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading

Introducing the MetaSight® G200: A Revolutionary Third-Generation Chromosomal Karyotyping System Transforming Global Chromosomal Analysis

Lianlian DigiTech Announces 2025 Annual Results

Unisound Posts Strong First Annual Results Since Listing: Revenue Surges Nearly 30%, H2 Loss Narrows Significantly by Over 90%, Profitability in Sight, Charting a New Course in Native Agentic AI

PROFIT ALERT: OnTime (09680.HK) Expects 2025 Revenue to Surge Over 100%, Profit to Rise at Least 43%

Lianlian DigiTech Achieves RMB3.3 Trillion in Total Payment Volume for 2024, Marking a 64.7% Year-on-Year Increase

menu
menu